2016년에서 2018년에 국내 말 인플루엔자 백신 접종 후 항체 양성률

• Published in: Korean journal of veterinary research Vol. 59; no. 3; pp. 151 - 155
• Main Authors: 조민수(Min-Su Cho), 이주연(Ju-Yeon Lee), 이상규(Sang Kyu Lee), 송재영(Jae Young Song), 이지현(Jienny Lee), 현방훈(Bang-Hun Hyun), 조수동(Soo-Dong Cho), 우인옥(In-Ohk Ouh)
• Format: Journal Article
• Language: Korean
• Published: 대한수의학회 2019
• Subjects: 수의학; horse; equine influenza virus (EIV); antibody; hemagglutination inhibition (HI)
• ISSN: 2466-1384; 2466-1392

Equine influenza (EI) is the main cause of respiratory illness in equines across the globe and is caused by equine influenza A virus (EIV-A), which has impacted the equine industry internationally because of the marginal mortality and high morbidity. In the present study, the immune responses after equine influenza vaccination were evaluated in 4,144 horses in Korea using the hemagglutination inhibition (HI) assay. The equine influenza virus (EIV), A/equine/South Africa/4/03 (H3N8), was used as the antigen in the HI assay. The mean seropositive rates were 89.2% (97.4% in 2016, 77.6% in 2017, and 92.4% in 2018). This paper highlights the advances in understanding the effects of vaccines and control strategies for mitigating the emerging menace by EIV.